What Happens When Medication Stops When GLP-1 medications are discontinued, weight regain is a common outcome
Reports in animal research suggest plasma growth hormone concentrations rose significantly after exposure, in some cases lasting several days
In addition to weight loss, GLP-1 RAs improve metabolic health in youth with obesity
Excitatory amino acid transporters EAAT-1 and EAAT-2 in temporal lobe and hippocampus in intractable temporal lobe epilepsy
There is no authorised UK reconstitution ratio for retatrutide
Collectively, these signals indicate that additional regulatory guidance or policy refinement may be forthcoming as the Agency continues to assess safety, quality, and appropriate use within this category (FDA, 2024)